RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
van der Kouwe, Emiel, Staber, Philipp Bernhard
Published in International journal of molecular sciences (16.01.2019)
Published in International journal of molecular sciences (16.01.2019)
Get full text
Journal Article
Translational regulation mechanisms of AP-1 proteins
Vesely, Paul Willi, Staber, Philipp Bernhard, Hoefler, Gerald, Kenner, Lukas
Published in Mutation research (01.07.2009)
Published in Mutation research (01.07.2009)
Get full text
Journal Article
Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia
STABER, Philipp Bernhard, LINKESCH, Werner, ZAUNER, Dorothea, BEHAM-SCHMID, Christine, GUELLY, Christian, SCHAUER, Silvia, SILL, Heinz, HOEFLER, Gerald
Published in Oncogene (29.01.2004)
Published in Oncogene (29.01.2004)
Get full text
Journal Article
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Porpaczy, Edit, Tripolt, Sabrina, Hoelbl-Kovacic, Andrea, Gisslinger, Bettina, Bago-Horvath, Zsuzsanna, Casanova-Hevia, Emilio, Clappier, Emmanuelle, Decker, Thomas, Fajmann, Sabine, Fux, Daniela A., Greiner, Georg, Gueltekin, Sinan, Heller, Gerwin, Herkner, Harald, Hoermann, Gregor, Kiladjian, Jean-Jacques, Kolbe, Thomas, Kornauth, Christoph, Krauth, Maria-Theresa, Kralovics, Robert, Muellauer, Leonhard, Mueller, Mathias, Prchal-Murphy, Michaela, Putz, Eva Maria, Raffoux, Emmanuel, Schiefer, Ana-Iris, Schmetterer, Klaus, Schneckenleithner, Christine, Simonitsch-Klupp, Ingrid, Skrabs, Cathrin, Sperr, Wolfgang R., Staber, Philipp Bernhard, Strobl, Birgit, Valent, Peter, Jaeger, Ulrich, Gisslinger, Heinz, Sexl, Veronika
Published in Blood (16.08.2018)
Published in Blood (16.08.2018)
Get full text
Journal Article
Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib
Pichler, Alexander, Kornauth, Christoph, Garces De Los Fayos Alonso, Ines, Kazianka, Lukas, Zibat, Arne, Mologni, Luca, Alachram, Halima, Pemovska, Tea, Heller, Gerwin, Greil, Richard, Kenner, Lukas, Jaeger, Ulrich, Staber, Philipp Bernhard
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Tislelizumab Plus Zanubrutinib in Patients with Richter Transformation: Primary Endpoint Analysis of the Prospective, Multi-Center, Phase-II RT1 Trial of the German CLL Study Group
Al-Sawaf, Othman, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Böttcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, Von Tresckow, Julia, Vehling-Kaiser, Ursula, Wendtner, Clemens-Martin, Fischer, Kirsten, Kreuzer, Karl Anton, Stilgenbauer, Stephan, Staber, Philipp Bernhard, Niemann, Carsten Utoft, Hallek, Michael, Eichhorst, Barbara F.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Endpoint Surrogacy in Chronic Lymphocytic Leukemia: A Pooled Analysis of the German CLL Study Group
Simon, Florian, Ligtvoet, Rudy, Robrecht, Sandra, Cramer, Paula, Kutsch, Nadine, Furstenau, Moritz, Goede, Valentin, Von Tresckow, Julia, Langerbeins, Petra, Fink, Anna-Maria, Huber, Henriette, Tausch, Eugen, Schneider, Christof, Wendtner, Clemens-Martin, Ritgen, Matthias, Dreyling, Martin, Müller, Lothar, Jacobasch, Lutz, Heinz, Werner, Vehling-Kaiser, Ursula, Sivcheva, Liliya, Böttcher, Sebastian, Dreger, Peter, Illmer, Thomas, Gregor, Michael, Staber, Philipp Bernhard, Stilgenbauer, Stephan, Niemann, Carsten Utoft, Kater, Arnon P., Fischer, Kirsten, Eichhorst, Barbara F., Hallek, Michael, Al-Sawaf, Othman
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia
Al-Sawaf, Othman, Fürstenau, Moritz, Giza, Adam, Robrecht, Sandra, Von Tresckow, Julia, Fink, Anna Maria, Simon, Florian, Tausch, Eugen, Schneider, Christof, Sivcheva, Liliya, Schwarer, Anthony, Loscertales, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah R., Juliusson, Gunnar, Da Cunha-Bang, Caspar, Illmer, Thomas, Gregor, Michael, Thornton, Patrick, Janssens, Ann, Tadmor, Tamar, Lindström, Vesa, Staber, Philipp Bernhard, Levin, Mark-David, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Ritgen, Matthias, Stilgenbauer, Stephan, Kater, Arnon P., Niemann, Carsten Utoft, Fischer, Kirsten, Eichhorst, Barbara F., Hallek, Michael
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
In Human Visualization of Ibrutinib-Induced CLL Compartment Shift
Mayerhoefer, Marius E, Haug, Alexander, Jaeger, Ulrich, Kazianka, Lukas, Pichler, Verena, Pfaff, Sarah, Wester, Hans-Jürgen, Hacker, Marcus, Staber, Philipp Bernhard
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Combination of Venetoclax and Ibrutinib Increases bcl2-Dependent Apoptotic Priming, Reduces ITK-Phosphorylation and Is Clinically Promising in Relapsed/Refractory T-Prolymphocytic Leukemia
Kornauth, Christoph, Herbaux, Charles, Boidol, Bernd, Guillemette, Chantal, Caron, Patrick, Poulain, Stéphanie, Tournilhac, Olivier, Mayerhoefer, Marius E, Jaeger, Ulrich, Kubicek, Stefan, Davids, Matthew S., Staber, Philipp Bernhard
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
Fürstenau, Moritz, Ritgen, Matthias, Robrecht, Sandra, Von Tresckow, Julia, Zhang, Can, Schilhabel, Anke, Gregor, Michael, Thornton, Patrick, Staber, Philipp Bernhard, Tadmor, Tamar, Lindström, Vesa, Juliusson, Gunnar, Janssens, Ann, Levin, Mark-David, Da Cunha-Bang, Caspar, Schneider, Christof, Goldschmidt, Neta, Vandenberghe, Elisabeth, Rossi, Davide, Benz, Rudolf A., Heintel, Daniel, Poulsen, Christian Bjørn, Christiansen, Ilse, Frederiksen, Henrik, Enggaard, Lisbeth, Posthuma, Eduardus, Issa, Djamila, Visser, Hein, Bellido, Mar, Kutsch, Nadine, Dürig, Jan, Stehle, Alexander, Voehringer, Matthias C., Böttcher, Sebastian, Schulte, Clemens, Simon, Florian, Fink, Anna-Maria, Fischer, Kirsten, Holmes, Emily, Kreuzer, Karl-Anton, Brüggemann, Monika, Tausch, Eugen, Stilgenbauer, Stephan, Hallek, Michael, Kater, Arnon P., Niemann, Carsten Utoft, Eichhorst, Barbara F.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation
Merkel, Olaf, Hamacher, Frank, Griessl, Robert, Grabner, Lisa, Schiefer, Ana-Iris, Prutsch, Nicole, Baer, Constance, Egger, Gerda, Schlederer, Michaela, Krenn, Peter William, Hartmann, Tanja Nicole, Simonitsch-Klupp, Ingrid, Plass, Christoph, Staber, Philipp Bernhard, Moriggl, Richard, Turner, Suzanne D, Greil, Richard, Kenner, Lukas
Published in The Journal of pathology (01.08.2015)
Published in The Journal of pathology (01.08.2015)
Get full text
Journal Article
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
Suske, Tobias, Sorger, Helena, Manhart, Gabriele, Ruge, Frank, Prutsch, Nicole, Zimmerman, Mark W, Eder, Thomas, Abdallah, Diaaeldin I, Maurer, Barbara, Wagner, Christina, Schönefeldt, Susann, Spirk, Katrin, Pichler, Alexander, Pemovska, Tea, Schweicker, Carmen, Pölöske, Daniel, Hubanic, Emina, Jungherz, Dennis, Müller, Tony Andreas, Aung, Myint Myat Khine, Orlova, Anna, Pham, Ha Thi Thanh, Zimmel, Kerstin, Krausgruber, Thomas, Bock, Christoph, Müller, Mathias, Dahlhoff, Maik, Boersma, Auke, Rülicke, Thomas, Fleck, Roman, de Araujo, Elvin Dominic, Gunning, Patrick Thomas, Aittokallio, Tero, Mustjoki, Satu, Sanda, Takaomi, Hartmann, Sylvia, Grebien, Florian, Hoermann, Gregor, Haferlach, Torsten, Staber, Philipp Bernhard, Neubauer, Heidi Anne, Look, Alfred Thomas, Herling, Marco, Moriggl, Richard
Published in The Journal of clinical investigation (15.04.2024)
Published in The Journal of clinical investigation (15.04.2024)
Get full text
Journal Article
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor
Staber, Philipp Bernhard, Jurczak, Wojciech, Greil, Richard, Vucinic, Vladan, Middeke, Jan Moritz, Montillo, Marco, Munir, Talha, Neumeister, Peter, Schetelig, Johannes, Stilgenbauer, Stephan, Striebel, Frank, Dirnberger-Hertweck, Maren, Weirather, Johannes, Brugger, Wolfram, Kelemen, Peter, Wendtner, Clemens-Martin, Woyach, Jennifer Ann
Published in Leukemia & lymphoma (06.12.2021)
Published in Leukemia & lymphoma (06.12.2021)
Get full text
Journal Article
A Phase Ib, Open-Label, Randomized Study to Assess Safety and Preliminary Efficacy of Tafasitamab (MOR208) or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: The First-Mind Trial
Burke, John M, André, Marc, Cheson, Bruce D., Duell, Johannes, Nowakowski, Grzegorz, Rosenwald, Andreas, Salles, Gilles A., Sharman, Jeff P., Staber, Philipp Bernhard, Trněný, Marek, Westin, Jason R., Brugger, Wolfram, Fingerle-Rowson, Günter, Klanova, Magdalena, Würth, Guido, Truemper, Lorenz
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Imatinib +/- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR
Staber, Philipp Bernhard, Kornauth, Christoph, Garces de los Fayos Alonso, Ines, Woessmann, Wilhelm, Klapper, Wolfram, Lagger, Sabine, Schiefer, Ana-Iris, Skrabs, Cathrin, Merkel, Olaf, Mayerhoefer, Marius E, Greil, Richard, Simonitsch-Klupp, Ingrid, Kenner, Lukas, Jaeger, Ulrich
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Two-Cohort Phase II Study in R/R CLL (COSMOS): First Preliminary Safety and Efficacy Results of Anti-CD19 MOR208 Treatment in Combination with Venetoclax in Patients Who Discontinued Prior BTK Inhibitor Therapy
Staber, Philipp Bernhard, Chanan-Khan, Asher A., Munir, Talha, Niederweiser, Dietger, Schetelig, Johannes, Middeke, Jan Moritz, Dirnberger-Hertweck, Maren, Kelemen, Peter, Weirather, Johannes, Parikh, Sameer A., Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Woyach, Jennifer A.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Primary Analysis of Anti-CD19 Tafasitamab (MOR208) Treatment in Combination with Idelalisib or Venetoclax in R/R CLL Patients Who Failed Prior BTK Inhibitor Therapy (COSMOS Trial)
Staber, Philipp Bernhard, Jurczak, Wojciech, Brugger, Wolfram, Chanan-Khan, Asher A., Greil, Richard, Hellmann, Andrzej, Dirnberger-Hertweck, Maren, Kelemen, Peter, Middeke, Jan Moritz, Montillo, Marco, Motta, Marina, Munir, Talha, Neumeister, Peter, Niederweiser, Dietger, Parikh, Sameer A., Schetelig, Johannes, Stilgenbauer, Stephan, Vucinic, Vladan, Weirather, Johannes, Woyach, Jennifer, Wendtner, Clemens-Martin
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Characterizing the Anti-Apoptotic Dependencies of T-Cell Prolymphocytic Leukemia Identifies HDAC and JAK/STAT Pathway Inhibitors As Promising Combination Partners to Augment Bcl-2 Targeted Killing By Venetoclax
Herbaux, Charles, Kornauth, Christoph, Poulain, Stéphanie, Tournilhac, Olivier, Collins, Mary C, Valentin, Rebecca, Chong, Stephen Jun Fei, Dupuis, Jehan, Daniel, Adrien, Srour, Micha, Tomowiak, Cecile, Laribi, Kamel, Roos-Weil, Damien, Rossi, Cedric, Vanlangendonck, Nicolas, Leyronnas, Cecile, Merabet, Fatiha, Malfuson, Jean Valère, Tiab, Mourad, Ng, Samuel, Morschhauser, Franck, Staber, Philipp Bernhard, Davids, Matthew S.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article